Amygdala Neurosciences, Inc.

Palo Alto, CA

UEI
QWM8J29664Y5
CAGE
7W4G8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
509 Hale St, Palo Alto, CA 94301, USA
Website
amygns.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Investigational new drug (IND)-enabling and early-stage development of selective, reversible, orally bioavailable ALDH2… U43AA030689 National Institute on Alcohol Abuse and Alcoholism (NIH) $4,110,000
Discovery next generation inhibitors of ALDH2 to reduce craving and alcohol consumption in alcohol use disorders… R43AA029311 National Institute on Alcohol Abuse and Alcoholism (NIH) $673,500
26- & 39-week toxicity studies of ANS-6637 in rats and monkeys (respectively) to enable 6+ months dosing in alcohol… U01AA028003 National Institute on Alcohol Abuse and Alcoholism (NIH) $1,350,000

Similar vendors

Vendor Location Primary NAICS
Epivario Inc. UEI M6ZTFQ3K1WT3 Philadelphia, PA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Camino Pharma LLC UEI K6JUDA59JJ17 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Afasci, Inc. UEI UGMEBNM4WSL6 Burlingame, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Artiam Bio Inc. UEI FKJAXBQEDUJ8 Cary, NC 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Makscientific LLC UEI J2NHTDAJGK24 Burlington, MA 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Amygdala Neurosciences, Inc., doing business as Amygdala Neurosciences Inc., is a biopharmaceutical company focused on developing and commercializing first-in-class therapies for addiction disorders. Their mission is to invent and develop medicines to treat substance use disorders. Amygdala Neurosciences is registered in SAM.gov as a for-profit corporate entity able to receive federal awards.

Amygdala Neurosciences has received several grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a subsidiary of the National Institutes of Health (NIH), under the Alcohol Research Programs (CFDA 93.273). A $2 million cooperative agreement funds development of their selective, reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor ANS-00858 to treat alcohol use disorder, including efficacy studies in animal models and IND-enabling activities. A $673,500 project grant supports discovery of next-generation potent, selective, reversible ALDH2 inhibitors using an innovative screening approach to reduce alcohol craving and consumption while avoiding off-target effects seen with disulfiram. Another $1.35 million cooperative agreement funded 26- and 39-week toxicity studies in rats and monkeys, respectively, for their compound ANS-6637 to enable longer-term dosing in Phase 3 trials for alcohol and substance use disorders. Amygdala's grant work aims to develop improved, safer pharmacotherapies targeting the ALDH2 enzyme for treating addictions.

Quick answers

Is Amygdala Neurosciences, Inc. registered in SAM.gov?

Yes. Amygdala Neurosciences, Inc.'s SAM.gov registration is active through August 15, 2027.

What is Amygdala Neurosciences, Inc.'s most recent federal award?

Amygdala Neurosciences, Inc.'s most recent federal grant award is Investigational new drug (IND)-enabling and early-stage development of selective, reversible, orally bioavailable ALDH2… (U43AA030689), from National Institute on Alcohol Abuse and Alcoholism (NIH), on August 1, 2023.

On GovTribe

See Amygdala Neurosciences, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login